Bisphosphonate Drug Holiday Increases Fracture Risk in Postmenopausal Women
The risk of developing fracture in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy was evaluated in a retrospective study.
The risk of developing fracture in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy was evaluated in a retrospective study.
The trabecular bone score may provides an acute, albeit indirect, measurement of bone quality in patients with type 2 diabetes.
Data were collected from the Osteoarthritis Initiative to examine the relationship between knee osteoarthritis and hypertension.
Patients with rheumatoid arthritis (RA) were evaluated at a specialized clinic to determine the relationship between knee osteoarthritis and elevated Disease Activity Scores (DAS28).
Researchers examined body mass index differences in current, past, and never users of menopausal hormone therapy.